HELPNasdaqPharmaceutical PreparationsFiscal year ends March 31
Helus Pharma Inc.
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 40-F on Jun 29, 2026
$10.69+0.14 (+1.33%)
Close on Oct 19, 2026
Helus Pharma statistics
Financials through Mar 31, 2026, price-based ratios appear once a share price is available, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Helus Pharma | Industry median |
|---|---|---|
| Market Cap | C$787.57M | C$123.83M |
| Enterprise Value | C$787.57M | C$93.80M |
Shares
| Measure | Helus Pharma | Industry median |
|---|---|---|
| Shares Outstanding | 51,631,800 | 74,643,400 |
| Shares Change (YoY) | 72.1% | 18.0% |
| Float | 42,442,400 | 74,292,200 |
| Shares Held by Insiders | 17.8% | 0.00% |
Calculated by StockData from Helus Pharma's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.